Cargando…

Immune Checkpoint Inhibitors as Therapy to Down-Stage Hepatocellular Carcinoma Prior to Liver Transplantation

SIMPLE SUMMARY: Hepatocellular Carcinoma (HCC) is one of the most common malignancies in the world with increasing prevalence. This review addresses the current and growing body of literature on the use of immune checkpoint inhibitors in patients with advanced HCC prior to liver transplantation and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katariya, Nitin N., Lizaola-Mayo, Blanca C., Chascsa, David M., Giorgakis, Emmanouil, Aqel, Bashar A., Moss, Adyr A., Uson Junior, Pedro Luiz Serrano, Borad, Mitesh J., Mathur, Amit K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101696/ https://www.ncbi.nlm.nih.gov/pubmed/35565184 http://dx.doi.org/10.3390/cancers14092056

Ejemplares similares

Donation after circulatory death transplant outcomes using livers recovered by local surgeons
por: Jadlowiec, Caroline C., et al.
Publicado: (2022)

Outcomes of endoscopic retrograde cholangiography and percutaneous transhepatic biliary drainage in liver transplant recipients with a Roux-en-Y biliary-enteric anastomosis
por: Kohli, Divyanshoo Rai, et al.
Publicado: (2023)

Solid pancreas transplant: Pushing forward
por: Giorgakis, Emmanouil, et al.
Publicado: (2018)

Decreasing Significance of Early Allograft Dysfunction with Rising Use of Nonconventional Donors
por: Ohara, Stephanie, et al.
Publicado: (2022)

Hepatoid Carcinoma of the Pancreas: Case Report, Next-Generation Tumor Profiling, and Literature Review
por: Chang, James M., et al.
Publicado: (2016)

Clinical Utility of Ivosidenib in the Treatment of IDH1-Mutant Cholangiocarcinoma: Evidence To Date
por: Uson Junior, Pedro Luiz Serrano, et al.
Publicado: (2023)

Exogenous copper exposure causing clinical wilson disease in a patient with copper deficiency
por: Lizaola-Mayo, Blanca C., et al.
Publicado: (2021)

Transjugular intrahepatic portosystemic shunt-induced hemolysis in a non-cirrhotic patient: a case report
por: Barnhill, Michele, et al.
Publicado: (2023)

Hepatocellular Carcinoma, Alpha Fetoprotein, and Liver Allocation for Transplantation: Past, Present and Future
por: Ruch, Brianna, et al.
Publicado: (2022)

Recent advances in understanding cholangiocarcinoma
por: Uson Junior, Pedro Luiz Serrano, et al.
Publicado: (2020)

Liver Transplant in a Polymerase Chain Reaction–Positive COVID-19 Recipient: A Case Report
por: Okubo, Keita, et al.
Publicado: (2021)

Acute Kidney Injury Patterns Following Transplantation of Steatotic Liver Allografts
por: Jadlowiec, Caroline, et al.
Publicado: (2020)

Cytomegalovirus infection after liver transplantation
por: Lizaola-Mayo, Blanca C, et al.
Publicado: (2020)

Solid Organ Transplantation From SARS-CoV-2–infected Donors to Uninfected Recipients: A Single-center Experience
por: Jayasekera, Channa R., et al.
Publicado: (2022)

Identifying Patterns of Adverse Events of Solid Organ Transplantation Through Departmental Case Reviews
por: Mathur, Amit K., et al.
Publicado: (2019)

Successful treatment of visceral pseudoaneurysm after pancreatectomy using flow-diverting stent device
por: Giorgakis, Emmanouil, et al.
Publicado: (2020)

Diffuse Hemorrhagic Enterocolitis in the Setting of 2019 Coronavirus
por: Lizaola-Mayo, Blanca, et al.
Publicado: (2022)

Nontraditional Use of TEE to Evaluate Hepatic Vasculature and Guide Surgical Management in Orthotopic Liver Transplantation
por: Khurmi, Narjeet, et al.
Publicado: (2019)

Gut microbiome dysbiosis in the setting of solid organ transplantation: What we have gleaned from human and animal studies
por: Sharma, Aparna, et al.
Publicado: (2022)

Pretransplant Fasting Glucose Predicts New-Onset Diabetes after Liver Transplantation
por: Carey, Elizabeth J., et al.
Publicado: (2012)

Cálculo tensorial : para ingenieros /
por: Serrano Lizaola, Raúl
Publicado: (1994)

Pretransplant Risk Score for New-Onset Diabetes After Kidney Transplantation
por: Chakkera, Harini A., et al.
Publicado: (2011)

Immune checkpoint inhibitor therapy in a liver transplant recipient with autoimmune disease and metastatic cutaneous squamous cell carcinoma
por: Brumfiel, Caitlin M., et al.
Publicado: (2021)

Ex vivo tracing of pancreatic neuroendocrine tumors with bio-conjugated fluorescent quantum dots: a paradigm of nanoparticle-based diagnostics
por: Giorgakis, Emmanouil, et al.
Publicado: (2015)

Application of resuscitative endovascular balloon occlusion in post-transplant mycotic hepatic artery pseudoaneurysm rupture in the setting of Aspergillus Constellatus bacteremia
por: Stephenson, Krista, et al.
Publicado: (2021)

Portal Vein Embolization: Impact of Chemotherapy and Genetic Mutations
por: Deipolyi, Amy R., et al.
Publicado: (2017)

Patterns of Care and Outcomes in Cardiovascular Disease After Kidney Transplantation in the United States
por: Mathur, Amit K., et al.
Publicado: (2017)

Acuity circles allocation policy impact on waitlist mortality and donation after circulatory death liver transplantation: A nationwide retrospective analysis
por: Giorgakis, Emmanouil, et al.
Publicado: (2023)

Factors associated with adverse outcomes from cardiovascular events in the kidney transplant population: an analysis of national discharge data, hospital characteristics, and process measures
por: Mathur, Amit K., et al.
Publicado: (2019)

FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical Practice
por: Kommalapati, Anuhya, et al.
Publicado: (2021)

Hospital resource intensity and cirrhosis mortality in United States
por: Mathur, Amit K, et al.
Publicado: (2017)

Association of DGF and Early Readmissions on Outcomes Following Kidney Transplantation
por: Jadlowiec, Caroline C., et al.
Publicado: (2022)

Beta-blockers and physical frailty in patients with end-stage liver disease
por: Kuo, Selena Z, et al.
Publicado: (2018)

Immunotherapy in biliary tract cancers: Current evidence and future perspectives
por: Uson Junior, Pedro Luiz Serrano, et al.
Publicado: (2022)

Advances in systemic therapy for advanced pancreatobiliary malignancies
por: Halfdanarson, Thorvardur R, et al.
Publicado: (2013)

Oncolytic Adenoviruses in Gastrointestinal Cancers
por: Yokoda, Raquel T., et al.
Publicado: (2018)

Hypoxia-Activated Alkylating Agents in BRCA1-Mutant Ovarian Serous Carcinoma
por: Conroy, Michael, et al.
Publicado: (2017)

Down Selection Criteria and MDs Prior to LS3
por: Arduini, G
Publicado: (2015)

Circulating Cell-Free Tumor DNA in Advanced Pancreatic Adenocarcinoma Identifies Patients With Worse Overall Survival
por: Botrus, Gehan, et al.
Publicado: (2022)

Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancements
por: Perisetti, Abhilash, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6kreq72bjk6k39aal6k6vcdk0n